Table 3. Institutional conflict of interest policies.

“Relative risk of receipt of payments” represents the incremental relative risk of a physician receiving one or more payments from any of the manufacturers of the drugs in that cancer type's choice set, associated with a 1‐point increase in Institute on Medicine as a Profession (IMAP) institutional conflict of interest (COI) policy score (with zero being least stringent and six being most stringent). “Relative risk of prescribing” represents the incremental relative risk of prescribing the paid drug, associated with a 1‐point increase in institutional IMAP COI policy score. Only physicians associated with the academic medical centers evaluated by IMAP are included.

Abbreviations: CI, confidence interval; CML, chronic myeloid leukemia.